Quanterix Debuts Content Innovation Engine with Akoya Biosciences at AACR 2026

Key Facts

1Quanterix announced the debut of its Content Innovation Engine at the American Association for Cancer Research (AACR) Annual Meeting 2026.

2The engine is built on the integration of Akoya Biosciences' spatial biology platform and Quanterix's SIMOA technology.

Quanterix Corporation and Akoya Biosciences have debuted their joint Content Innovation Engine ahead of the AACR Annual Meeting 2026 in San Diego. This framework integrates SIMOA technology with spatial biology to offer researchers ultra-sensitive diagnostic insights into cancer hallmarks. Joining the high-profile event, Agilent Technologies will showcase new oncology solutions, including advanced cell imaging and AI-enabled analysis software. Additionally, Natera (NTRA) has announced its participation, presenting 20 abstracts and two oral presentations that highlight its precision medicine and oncology platform. Natera's research spans multiple tumor types, contributing a significant volume of clinical data to the conference. These combined announcements underscore a major technological surge in the biotech sector, driven by AI and cell-free DNA innovations. The integration of these technologies is expected to enhance research efficiency and long-term growth for the global oncological community.

5 months ago

Version History

Version 25 months ago

What changed: Natera was added to the list of major biotech participants at the AACR 2026 conference, contributing 20 research abstracts focused on precision medicine.

Version 15 months ago

What changed: The story was expanded to include Agilent Technologies' participation at AACR 2026, highlighting their AI-driven diagnostics and cell imaging workflows, along with specific dates and location for the event.